Tankyrase promotes telomere elongation in human cells - PubMed (original) (raw)
Tankyrase promotes telomere elongation in human cells
S Smith et al. Curr Biol. 2000.
Free article
Abstract
Human telomeres are maintained by telomerase, a reverse transcriptase that adds telomeric repeats to chromosome ends [1,2]. In human tumors and immortalized cells, telomeres are often maintained at a constant length setting [3,4], indicating that telomerase-mediated telomere elongation is tightly regulated. Tankyrase, a telomeric poly(ADP-ribose) polymerase (PARP) [5], was identified through its interaction with TRF1 [6], a negative regulator of telomere extension by telomerase [7]. Tankyrase-mediated ADP-ribosylation inhibits binding of TRF1 to telomeric repeats in vitro [5], suggesting that tankyrase might regulate TRF1 and therefore control telomere dynamics in vivo. Here, we present evidence that tankyrase acts as a positive regulator of telomere elongation in vivo, apparently by inhibiting TRF1. Overexpression of tankyrase in the nucleus diminished the level of unmodified TRF1 in immunoblots and led to reduced immunofluorescence of TRF1 at interphase telomeres. Long-term overexpression of tankyrase in telomerase-positive human cells resulted in a gradual and progressive elongation of telomeres. A PARP-deficient form of tankyrase failed to affect TRF1 and did not alter telomere length dynamics, consistent with ADP-ribosylation of TRF1 as the main cause of altered telomere homeostasis. Our results indicate that tankyrase can induce telomere elongation in human cells. We propose that tankyrase-mediated ADP-ribosylation of TRF1 opens the telomeric complex, allowing access to telomerase.
Similar articles
- Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres.
Cook BD, Dynek JN, Chang W, Shostak G, Smith S. Cook BD, et al. Mol Cell Biol. 2002 Jan;22(1):332-42. doi: 10.1128/MCB.22.1.332-342.2002. Mol Cell Biol. 2002. PMID: 11739745 Free PMC article. - TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex.
Ye JZ, de Lange T. Ye JZ, et al. Nat Genet. 2004 Jun;36(6):618-23. doi: 10.1038/ng1360. Epub 2004 May 9. Nat Genet. 2004. PMID: 15133513 - Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation.
Muramatsu Y, Tahara H, Ono T, Tsuruo T, Seimiya H. Muramatsu Y, et al. Exp Cell Res. 2008 Mar 10;314(5):1115-24. doi: 10.1016/j.yexcr.2007.12.005. Epub 2007 Dec 14. Exp Cell Res. 2008. PMID: 18221737 - [The role of telomere-binding proteins in carcinogenesis].
Aragona M, Pontoriero A, Panetta S, La Torre I, La Torre F. Aragona M, et al. Minerva Med. 2000 Nov-Dec;91(11-12):299-304. Minerva Med. 2000. PMID: 11253711 Review. Italian. - The telomeric PARP, tankyrases, as targets for cancer therapy.
Seimiya H. Seimiya H. Br J Cancer. 2006 Feb 13;94(3):341-5. doi: 10.1038/sj.bjc.6602951. Br J Cancer. 2006. PMID: 16421589 Free PMC article. Review.
Cited by
- SUMOylated Golgin45 associates with PML-NB to transcriptionally regulate lipid metabolism genes during heat shock stress.
Jing S, Gao J, Tiwari N, Du Y, Zhu L, Gim B, Qian Y, Yue X, Lee I. Jing S, et al. Commun Biol. 2024 May 6;7(1):532. doi: 10.1038/s42003-024-06232-3. Commun Biol. 2024. PMID: 38710927 Free PMC article. - RNF166 promotes colorectal cancer progression by recognizing and destabilizing poly-ADP-ribosylated angiomotins.
Li Y, Zhang X, Liu N, Liu R, Zhang W, Chen L, Chen Y. Li Y, et al. Cell Death Dis. 2024 Mar 13;15(3):211. doi: 10.1038/s41419-024-06595-9. Cell Death Dis. 2024. PMID: 38480683 Free PMC article. - Unlocking longevity: the role of telomeres and its targeting interventions.
Schellnegger M, Hofmann E, Carnieletto M, Kamolz LP. Schellnegger M, et al. Front Aging. 2024 Jan 25;5:1339317. doi: 10.3389/fragi.2024.1339317. eCollection 2024. Front Aging. 2024. PMID: 38333665 Free PMC article. Review. - Tankyrase: a promising therapeutic target with pleiotropic action.
Sagathia V, Patel C, Beladiya J, Patel S, Sheth D, Shah G. Sagathia V, et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3363-3374. doi: 10.1007/s00210-023-02576-5. Epub 2023 Jun 20. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 37338576 Review. - VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry.
Delgado-Bellido D, Zamudio-Martínez E, Fernández-Cortés M, Herrera-Campos AB, Olmedo-Pelayo J, Perez CJ, Expósito J, de Álava E, Amaral AT, Valle FO, Diaz AG, Oliver FJ. Delgado-Bellido D, et al. Cell Death Dis. 2023 Feb 17;14(2):135. doi: 10.1038/s41419-023-05666-7. Cell Death Dis. 2023. PMID: 36797281 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources